skip to Main Content

Epidiolex Causes Giant Shift in Cannabis Scheduling

Not to be content with being the first approved CBD-derived drug for treatment of epilepsy, GW Pharmaceutical’s Epidiolex is causing the Drug Enforcement Agency’s stance on cannabis to change. Epidiolex’s rescheduling is the first time in 46 years that the…

Read More

InstantGMP™ Release Notes for Version 3.009.001

New Functionalities Like MPRs, BPRs now have a “view only mode” of their Manufacturing Instructions. This “view only mode” appears after the BPR has been Reviewed, Rejected or Added to Inventory. Each Manufacturing Instruction step in a BPR is “locked”…

Read More

FDA Cracking Down on Underaged E-Cigarette Use

In a press release posted September 12th, 2018 by the Food and Drug Administration (FDA), the agency announced several details about enforcement actions for the e-cigarette industry. Dr. Scott Gottlieb, FDA Commissioner also released a statement regarding ongoing agency efforts.…

Read More

InstantGMP™ Release notes for version 3.009.001

New Functionalities Like MPRs, BPRs now have a “view only mode” of their Manufacturing Instructions. This “view only mode” appears after the BPR has been Reviewed, Rejected or Added to Inventory. Each Manufacturing Instruction step in a BPR is “locked”…

Read More

Oklahoma Joins the Medical Marijuana Green Rush

Last week, the heartland state of Oklahoma opened applications for the state’s brand new medical marijuana program and thousands answered the call. On the first day alone, more than 1,600 companies and individuals submitted applications after the system went live.…

Read More
Back To Top